Monocyte activation in patients with Wegener's granulomatosis

被引:80
作者
Kobold, ACM [1 ]
Kallenberg, GGM [1 ]
Tervaert, JWC [1 ]
机构
[1] Univ Groningen Hosp, Dept Clin Immunol, NL-9700 RB Groningen, Netherlands
关键词
D O I
10.1136/ard.58.4.237
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Wegener's granulomatosis (WG) is an inflammatory disorder characterised by granulomatous inflammation, vasculitis, and necrotising vasculitis and is strongly associated with anti-neutrophil cytoplasmic antibodies (ANCA). Activated monocytes/macrophages are present in renal biopsy specimens and participate in granuloma formation by synthesising and secreting a variety of chemoattractants, growth factors, and cytokines. In view of these findings, in vivo monocyte activation was evaluated in patients with WG and the findings related to parameters of clinical disease activity. Methods-Monocyte activation was analysed by measuring plasma concentrations of soluble products of monocyte activation, that is neopterin and interleukin 6 (IL6), by ELISA, and by quantitating the surface expression of activation markers on circulating monocytes by how cytometry. Results-Twenty four patients with active WG were included in this study. Ten of these patients were also analysed at the time of remission. Twelve patients with sepsis served as positive controls, and 10 healthy volunteers as negative controls for monocyte activation. Patients with active disease had increased monocyte activation compared with healthy controls as shown by increased concentrations of neopterin (p < 0.0001) and increased surface expression of CD11b (p < 0.05) and CD64 (p < 0.05), In those patients with increased concentrations of IL6 during active disease plasma concentrations of IL6 decreased during follow up when patients went into remission (p < 0.0001). In addition, neopterin (r = 0.37, r = 0.44), IL6 (r = 0.37, r = 0.60) and CD63 expression (r = 0.39, r = 0.45) correlated significantly with disease activity as measured by the Birmingham Vasculitis Activity Score and C reactive protein values, respectively. Compared with patients with sepsis, all markers of monocyte activation in patients with vasculitis were lower. Conclusion-It is concluded that disease activity in WG correlates with the extent of activation of monocytes, compatible with their role in the pathophysiology of this disease.
引用
收藏
页码:237 / 245
页数:9
相关论文
共 45 条
[1]  
AULITZKY WE, 1988, CLIN NEPHROL, V29, P248
[2]  
CASSELMAN BL, 1995, J LAB CLIN MED, V126, P495
[3]   ANTIBODIES AGAINST GRANULE PROTEINS ACTIVATE NEUTROPHILS INVITRO [J].
CHARLES, LA ;
CALDAS, MLR ;
FALK, RJ ;
TERRELL, RS ;
JENNETTE, JC .
JOURNAL OF LEUKOCYTE BIOLOGY, 1991, 50 (06) :539-546
[4]  
CSERNOK E, 1994, CLIN EXP IMMUNOL, V95, P244
[5]   ANTIMYELOPEROXIDASE ANTIBODIES INDUCE NEUTROPHIL ADHERENCE TO CULTURED HUMAN ENDOTHELIAL-CELLS [J].
EWERT, BH ;
BECKER, ME ;
JENNETTE, JC ;
FALK, RJ .
RENAL FAILURE, 1995, 17 (02) :125-133
[6]   Development and initial validation of the vasculitis damage index for the standardized clinical assessment of damage in the systemic vasculitides [J].
Exley, AR ;
Bacon, PA ;
Luqmani, RA ;
Kitas, GD ;
Gordon, C ;
Savage, COS ;
Adu, D .
ARTHRITIS AND RHEUMATISM, 1997, 40 (02) :371-380
[7]   ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES INDUCE NEUTROPHILS TO DEGRANULATE AND PRODUCE OXYGEN RADICALS INVITRO [J].
FALK, RJ ;
TERRELL, RS ;
CHARLES, LA ;
JENNETTE, JC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (11) :4115-4119
[8]   CLINICAL COURSE OF ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODY-ASSOCIATED GLOMERULONEPHRITIS AND SYSTEMIC VASCULITIS [J].
FALK, RJ ;
HOGAN, S ;
CAREY, TS ;
JENNETTE, JC .
ANNALS OF INTERNAL MEDICINE, 1990, 113 (09) :656-663
[9]   WEGENERS GRANULOMATOSIS - PROSPECTIVE CLINICAL AND THERAPEUTIC EXPERIENCE WITH 85 PATIENTS FOR 21 YEARS [J].
FAUCI, AS ;
HAYNES, BF ;
KATZ, P ;
WOLFF, SM .
ANNALS OF INTERNAL MEDICINE, 1983, 98 (01) :76-85
[10]   THE ROLE OF NEOPTERIN AS A MONITOR OF CELLULAR IMMUNE ACTIVATION IN TRANSPLANTATION, INFLAMMATORY, INFECTIOUS, AND MALIGNANT DISEASES [J].
FUCHS, D ;
WEISS, G ;
REIBNEGGER, G ;
WACHTER, H .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1992, 29 (3-4) :307-341